The experimental data further validated the theoretical prediction, revealing that RA effectively inhibits COX-2 activity in the micromolar range and reduces A549 cell proliferation in non-small cell lung cancer (NSCLC) [81]. The gene discussed is PTGS2; the disease is non-small cell lung carcinoma.